Multiple Sclerosis
Conditions
Keywords
Gait deficit, PoNS
Brief summary
The Registry will be designed to gather information over 3 years. This important health economic information will help to establish the value of the PoNS Device on key therapeutic outcomes. These outcomes will include: disease-associated injury risks (i.e., falls), onset of new comorbidities and/or worsening/improvement of existing medical condition(s) (other than gait deficit/impairment), need for new pharmacological/non-pharmacological intervention or increase/decrease of ongoing pharmacotherapy or other non-pharmacological intervention, increase/decrease of in patient/outpatient hospital and/or office visits or stays, side effects. By participation in the Registry, patients and physicians will be providing Helius with access to information about medical history, medical diagnoses, clinical symptom presentations, vocational information, medications, pharmacologic and non-pharmacologic prescriptions, hospitalization and healthcare visits, and any reported therapy's adverse events.
Interventions
No intervention
Sponsors
Helius Medical Inc
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No
Inclusion criteria
none * Diagnosis of gait deficit due to MS
Exclusion criteria
none * unable to ambulate with or without an assisting device
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Effectiveness of PoNS Therapy as measured by self-reported change in symptomatology | 3 years | Balance and Gait deficit improvement after physical therapy rehabilitation with PoNS device over one or more courses of 14-week therapy |
Countries
United States
Outcome results
None listed